ClinicalTrials.gov
public full text
Public Domain
Irreversible Electroporation Versus Standard Medication for Benign Prostatic Obstruction
Irreversible electroporation (IRE) is a novel ablation modality using electric pulses to create nanoscale defects in the cell membrane. It has been verified to be safe on the treatment of prostate, lung, liver and kidney masses. The present is a randomized, controlled trial, with a main purpose of looking into the safety and feasibility of irreversible electroporation for patients with benign prostatic obstruction.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy#878528
- Irreversible Electroporation of Unresectable Liver Tumors#995269
- Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study#834759
- A Study of Early Robotic Ablation by Substrate Elimination of Ventricular Tachycardia#867731
- Comparison of Different Electroporation Systems in the Ablation Treatment of Atrial Fibrillation#892101
Record · ID 895203
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive